HRP20110268T1 - Nova medicinska primjena alfa-ketoglutarata - Google Patents
Nova medicinska primjena alfa-ketoglutarata Download PDFInfo
- Publication number
- HRP20110268T1 HRP20110268T1 HR20110268T HRP20110268T HRP20110268T1 HR P20110268 T1 HRP20110268 T1 HR P20110268T1 HR 20110268 T HR20110268 T HR 20110268T HR P20110268 T HRP20110268 T HR P20110268T HR P20110268 T1 HRP20110268 T1 HR P20110268T1
- Authority
- HR
- Croatia
- Prior art keywords
- bacteria
- ureolytic
- application
- preparation
- ureolytic bacteria
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 claims abstract 25
- 230000003604 ureolytic effect Effects 0.000 claims abstract 23
- 238000002360 preparation method Methods 0.000 claims abstract 14
- 241000251468 Actinopterygii Species 0.000 claims abstract 10
- 208000015181 infectious disease Diseases 0.000 claims abstract 10
- 230000015572 biosynthetic process Effects 0.000 claims abstract 9
- 241000124008 Mammalia Species 0.000 claims abstract 8
- 241000251539 Vertebrata <Metazoa> Species 0.000 claims abstract 8
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 claims abstract 7
- 230000000694 effects Effects 0.000 claims abstract 7
- 241000282412 Homo Species 0.000 claims abstract 6
- 238000004519 manufacturing process Methods 0.000 claims abstract 5
- 241000202898 Ureaplasma Species 0.000 claims abstract 4
- 108010046334 Urease Proteins 0.000 claims abstract 4
- 235000015872 dietary supplement Nutrition 0.000 claims abstract 4
- 208000006558 Dental Calculus Diseases 0.000 claims abstract 3
- 241000590002 Helicobacter pylori Species 0.000 claims abstract 3
- 241000282414 Homo sapiens Species 0.000 claims abstract 3
- 208000002925 dental caries Diseases 0.000 claims abstract 3
- 235000013305 food Nutrition 0.000 claims abstract 3
- 229940037467 helicobacter pylori Drugs 0.000 claims abstract 3
- 230000002458 infectious effect Effects 0.000 claims abstract 3
- 210000000214 mouth Anatomy 0.000 claims abstract 3
- 238000011282 treatment Methods 0.000 claims abstract 3
- 230000002485 urinary effect Effects 0.000 claims abstract 3
- 241000589562 Brucella Species 0.000 claims abstract 2
- 241000186216 Corynebacterium Species 0.000 claims abstract 2
- 241000588748 Klebsiella Species 0.000 claims abstract 2
- 241000204048 Mycoplasma hominis Species 0.000 claims abstract 2
- 241000588769 Proteus <enterobacteria> Species 0.000 claims abstract 2
- 241000588770 Proteus mirabilis Species 0.000 claims abstract 2
- 241000588768 Providencia Species 0.000 claims abstract 2
- 241000589516 Pseudomonas Species 0.000 claims abstract 2
- 241000193395 Sporosarcina pasteurii Species 0.000 claims abstract 2
- 241000607734 Yersinia <bacteria> Species 0.000 claims abstract 2
- 230000001580 bacterial effect Effects 0.000 claims abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract 2
- 230000000241 respiratory effect Effects 0.000 claims abstract 2
- 210000002345 respiratory system Anatomy 0.000 claims abstract 2
- 210000002229 urogenital system Anatomy 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims 4
- 239000002699 waste material Substances 0.000 claims 3
- 241000252233 Cyprinus carpio Species 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 241000202921 Ureaplasma urealyticum Species 0.000 claims 2
- 230000033558 biomineral tissue development Effects 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 230000000968 intestinal effect Effects 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010054949 Metaplasia Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 206010044029 Tooth deposit Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000000718 duodenal ulcer Diseases 0.000 claims 1
- 239000013505 freshwater Substances 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 201000011587 gastric lymphoma Diseases 0.000 claims 1
- 210000004195 gingiva Anatomy 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000015689 metaplastic ossification Effects 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 230000001717 pathogenic effect Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 229940034610 toothpaste Drugs 0.000 claims 1
- 239000000606 toothpaste Substances 0.000 claims 1
- 210000001635 urinary tract Anatomy 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 241000271566 Aves Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 241001430197 Mollicutes Species 0.000 abstract 1
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 239000003674 animal food additive Substances 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 208000024693 gingival disease Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 210000005000 reproductive tract Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL380103A PL226695B1 (pl) | 2006-07-03 | 2006-07-03 | Środek do zastosowania w zapobieganiu i/lub hamowaniu kolonizacji Helicobacter pylori, zastosowanie soli kwasu alfa‑ketoglutarowego z metalami alkalicznymi i ziem alkalicznych do wytwarzania środka leczniczego oraz dodatku do żywności do zapobiegania i/lub hamowania kolonizacji Helicobacter pylori |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110268T1 true HRP20110268T1 (hr) | 2011-05-31 |
Family
ID=38984524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110268T HRP20110268T1 (hr) | 2006-07-03 | 2011-04-13 | Nova medicinska primjena alfa-ketoglutarata |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100124537A1 (da) |
| EP (1) | EP1917959B1 (da) |
| AT (1) | ATE495738T1 (da) |
| DE (1) | DE602007012036D1 (da) |
| DK (1) | DK1917959T3 (da) |
| ES (1) | ES2360142T3 (da) |
| HR (1) | HRP20110268T1 (da) |
| IL (1) | IL233342A (da) |
| PL (2) | PL226695B1 (da) |
| SI (1) | SI1917959T1 (da) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
| ES2511792T3 (es) | 2006-07-25 | 2014-10-23 | Vecta Ltd. | Composiciones y métodos para la inhibición de la secreción de ácido gástrico usando derivados de pequeños ácidos dicarboxílicos en combinación con IBP |
| SE0602446L (sv) * | 2006-11-16 | 2008-05-17 | Entress Ab | Ny användning av kända farmakologiskt aktiva kemiska sammansättningar |
| HUE033223T2 (hu) | 2010-11-29 | 2017-11-28 | Eurochit Danuta Kruszewska | Új nanotermék kórmegelõzésben, diagnosztikában, valamint orvosi és állatorvosi kezelésben való alkalmazásra |
| CN104684565A (zh) | 2012-05-29 | 2015-06-03 | 达努塔·克鲁谢夫斯卡 | 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途 |
| EP2674162A1 (en) | 2012-05-29 | 2013-12-18 | Danuta Kruszewska | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same |
| US9592211B2 (en) | 2012-09-19 | 2017-03-14 | Grespo Ab | Compositions for improvement of brain function |
| CN103923900B (zh) * | 2014-04-14 | 2016-03-23 | 江南大学 | 一种黄酒用双功能酶交联酶聚集体的制备与应用 |
| WO2018064468A1 (en) * | 2016-09-30 | 2018-04-05 | The Regents Of The University Of California | Alpha-ketobutyrate, alpha-ketoglutarate, and 2-hydroxybutyrate for stimulating hair growth |
| IL308093A (en) * | 2017-04-25 | 2023-12-01 | Buck Inst Res Aging | Formulations to extend life span and health |
| AU2019350699B2 (en) | 2018-09-25 | 2024-05-23 | Ponce De Leon Health Designated Activity Company | Process of making calcium alpha-ketoglutarate |
| EP3870184A4 (en) * | 2018-10-24 | 2022-07-20 | Ponce de Leon Health Designated Activity Company | NICOTINAMIDE RIBOSIDE COMPOSITIONS TO PROLONG HEALTHY LIFE |
| WO2022006500A1 (en) * | 2020-07-02 | 2022-01-06 | Ponce De Leon Health Designated Activity Company | Compositions and methods for treating crp-mediated diseases |
| CN115340313B (zh) * | 2022-01-17 | 2023-04-18 | 浙江理工大学 | 一种物理复合微生物技术强化再生骨料方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4919855B1 (da) | 1970-10-06 | 1974-05-21 | ||
| US4256731A (en) * | 1978-03-23 | 1981-03-17 | Beecham, Inc. | Oral Compositions |
| US5028412A (en) * | 1987-05-01 | 1991-07-02 | Purdue Research Foundation | Oral compositions comprising anti-calculus agents |
| US5817294A (en) * | 1990-11-02 | 1998-10-06 | Arnold; Michael J. | Plaque adsorbent oral composition and method |
| JP2002529545A (ja) * | 1998-11-06 | 2002-09-10 | ユニベルシテ ドゥ モントリオール | バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液 |
| FR2822704B1 (fr) * | 2001-03-29 | 2005-02-18 | Chiesi Sa | Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments |
| US7122578B2 (en) * | 2001-09-11 | 2006-10-17 | Alain Martin | Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration |
| SE0200256D0 (sv) * | 2001-12-21 | 2002-01-29 | Gramineer Internat Ab | New composition, methods and use |
| PL368572A1 (en) * | 2004-06-17 | 2005-12-27 | Sgp & Sons Ab | Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections |
| WO2007082914A2 (en) * | 2006-01-19 | 2007-07-26 | Entress Ab | Method of diagnosis and method of treatment |
| US7803817B2 (en) * | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
| CN101309678B (zh) | 2005-11-15 | 2011-04-20 | 安特瑞斯公司 | 用于与软骨损伤有关的应用的药物 |
-
2006
- 2006-07-03 PL PL380103A patent/PL226695B1/pl unknown
-
2007
- 2007-07-03 PL PL07460015T patent/PL1917959T3/pl unknown
- 2007-07-03 AT AT07460015T patent/ATE495738T1/de active
- 2007-07-03 DE DE602007012036T patent/DE602007012036D1/de active Active
- 2007-07-03 DK DK07460015.6T patent/DK1917959T3/da active
- 2007-07-03 SI SI200730571T patent/SI1917959T1/sl unknown
- 2007-07-03 EP EP07460015A patent/EP1917959B1/en active Active
- 2007-07-03 ES ES07460015T patent/ES2360142T3/es active Active
- 2007-07-03 US US12/452,485 patent/US20100124537A1/en not_active Abandoned
-
2011
- 2011-04-13 HR HR20110268T patent/HRP20110268T1/hr unknown
-
2014
- 2014-06-24 IL IL233342A patent/IL233342A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SI1917959T1 (sl) | 2011-05-31 |
| EP1917959A1 (en) | 2008-05-07 |
| PL1917959T3 (pl) | 2011-06-30 |
| PL226695B1 (pl) | 2017-08-31 |
| DK1917959T3 (da) | 2011-05-09 |
| PL380103A1 (pl) | 2008-01-07 |
| US20100124537A1 (en) | 2010-05-20 |
| EP1917959B1 (en) | 2011-01-19 |
| DE602007012036D1 (de) | 2011-03-03 |
| IL233342A (en) | 2016-05-31 |
| ATE495738T1 (de) | 2011-02-15 |
| IL233342A0 (en) | 2014-08-31 |
| ES2360142T3 (es) | 2011-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110268T1 (hr) | Nova medicinska primjena alfa-ketoglutarata | |
| JP2010532347A5 (da) | ||
| JP3875262B2 (ja) | 殺菌剤としての酸性化したニトリット | |
| Wang et al. | Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model | |
| JP5518702B2 (ja) | α−ケトグルタレートの新規の医学的用途 | |
| US8962683B2 (en) | Medium chain fatty acids applicable as anti-microbial agents | |
| US20060018843A1 (en) | Halitosis, gingivitis, and periodontitis treatment and preventative composition | |
| EP3054783A1 (en) | Composition of medium-chain fatty acids and feed supplemented with composition | |
| JP2019524877A5 (da) | ||
| JP4146146B2 (ja) | フロロタンニン類を主成分とする抗菌剤 | |
| WO2014057151A1 (es) | Uso de la cepa cect 7426 para provocar quorum quenching de la señal autoinductor-2 (ai-2) | |
| García et al. | Zoonotic infections: the role of biofilms | |
| Skřivanová et al. | In vitro effect of C 2–C 18 fatty acids on salmonellas | |
| RU2009124294A (ru) | Содержащая мирт композиция для гигиены полости рта | |
| WO2001097791A2 (fr) | Utilisation d'acides en c4-c10 pour la prévention des infections a bactéries a gram négatif | |
| Stefanou et al. | Pomegranate as an Antibacterial Agent against Pathogens and at the same Time Advantageous to Beneficial Bacteria: A Review | |
| JP2010095489A (ja) | 病原性細菌の毒素産生抑制剤 | |
| Nader | Masarwa., et al.“The Use of Probiotics in Prevention and Treatment of Oral Diseases” | |
| JP2010513431A5 (da) | ||
| Surendran Nair | Controlling Enterohemorrhagic E. coli O157: H7 using Selenium and Rutin | |
| Du Hyeon Hwang et al. | Skin sensitization test of potassium hydroxide in guinea pigs | |
| Sukumaran et al. | Can bio-nanotechnology be effective against multi drug resistant (MDR) pathogens? | |
| CN113350261A (zh) | 抗口腔幽门螺杆菌姜黄抑菌牙膏 | |
| RU2583890C2 (ru) | Способ лечения гингивитов, пародонтитов и зубного камня у собак | |
| Wang et al. | Recent Advances in Bacterial Biofilm Studies: Formation, Regulation, and Eradication in Human Infections |